[Rapid drug information].
D016907:Adverse Drug Reaction Reporting Systems / Q000331:legislation & jurisprudence*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D004346:Drug Information Services / Q000331:legislation & jurisprudence*; D005858:Germany; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use; D007571:Jaw Diseases / Q000139:chemically induced*; D009101:Multiple Myeloma / Q000188:drug therapy*; D010020:Osteonecrosis / Q000139:chemically induced*; D010024:Osteoporosis / Q000188:drug therapy*; D000077268:Pamidronate; D018570:Risk Assessment; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D000077268:Pamidronate